| 000 | 01293 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512214151.0 | ||
| 264 | 0 | _c19801218 | |
| 008 | 198012s 0 0 pol d | ||
| 022 | _a0034-6233 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrühl, W | |
| 245 | 0 | 0 |
_a[Clinical and immunological effects of treatment of rheumatoid arthritis with pyrithioxin (Enerbol Polfa)]. _h[electronic resource] |
| 260 |
_bReumatologia _c1980 |
||
| 300 |
_a241-8 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigen-Antibody Complex _xanalysis |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 |
_aDrug Eruptions _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Complex Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrithioxin _xadverse effects |
| 700 | 1 | _aSwierczyńska, Z | |
| 700 | 1 | _aSzymańska-Cygler, B | |
| 700 | 1 | _aDyznarowska, H | |
| 700 | 1 | _aChrzczonowski, Z | |
| 700 | 1 | _aLoth, E | |
| 700 | 1 | _aZabek, J | |
| 773 | 0 |
_tReumatologia _gvol. 18 _gno. 3 _gp. 241-8 |
|
| 999 |
_c6448349 _d6448349 |
||